Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization

SIMPLE SUMMARY: Radioembolization has failed to prove survival benefit in randomized trials, and, depending on various factors including tumor biology, response rates may vary considerably. Studies showed positive correlations between survival and absorbed tumor dose. Therefore, increasing currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Seidensticker, Max, Fabritius, Matthias Philipp, Beller, Jannik, Seidensticker, Ricarda, Todica, Andrei, Ilhan, Harun, Pech, Maciej, Heinze, Constanze, Powerski, Maciej, Damm, Robert, Weiss, Alexander, Rueckel, Johannes, Omari, Jazan, Amthauer, Holger, Ricke, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122451/
https://www.ncbi.nlm.nih.gov/pubmed/33919073
http://dx.doi.org/10.3390/cancers13091992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122451/
https://www.ncbi.nlm.nih.gov/pubmed/33919073
http://dx.doi.org/10.3390/cancers13091992

Ejemplares similares